|
|
|
 |
| Location: Home -
Products - API Intermediates - API Intermediates
|
Cevimeline hydrochloride
| Catalogue No. : |
C16157 |
| Product Name: |
Cevimeline hydrochloride |
| Synonym: |
AF 102B, SNI 2011;Saligren;Evoxac; FKS 508; SND 5008;SNK 508 |
| Chemical Name: |
cis-2-Methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride;(2'R,3R)-rel-2'-Methyl- spiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane] hydrochloride |
| CAS No. : |
107220-28-0 |
| Structure : |
|
| Molecular Formula: |
C10H17NOS.HCl |
| Molecular Weight: |
235.77 |
| Solubility: |
Soluble to 75 mM in water and to 50 mM in DMSO |
| Purity: |
>99% |
| Usage: |
Selective M1 receptor agonist. Induces atropine-sensitive contractions of isolated guinea pig ilea and trachea preparations (EC50 values are 3.5 and 3 μM respectively). Reverses AF64A-induced cognitive impairments in vivo. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
